These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Assessment of the effectiveness of three different cephalosporin/clavulanate combinations for the phenotypic confirmation of extended-spectrum beta-lactamase producing bacteria isolated from urine samples at National Public Health Laboratory, Kathmandu, Nepal. Bhandari R, Pant ND, Poudel A, Sharma M. BMC Res Notes; 2016 Aug 04; 9():390. PubMed ID: 27488224 [Abstract] [Full Text] [Related]
16. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. Pokharel BM, Koirala J, Dahal RK, Mishra SK, Khadga PK, Tuladhar NR. Int J Infect Dis; 2006 Nov 04; 10(6):434-8. PubMed ID: 16978898 [Abstract] [Full Text] [Related]
18. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ. J Microbiol Immunol Infect; 2011 Oct 04; 44(5):364-8. PubMed ID: 21524974 [Abstract] [Full Text] [Related]
19. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections]. Hoşbul T, Ozyurt M, Baylan O, Bektöre B, Ardiç N, Ceylan S, Erdemoğlu A, Haznedaroğlu T. Mikrobiyol Bul; 2009 Oct 04; 43(4):645-9. PubMed ID: 20084918 [Abstract] [Full Text] [Related]